The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Increased Sympathetic Nerve Activity in Pulmonary Artery Hypertension
Open accessAbstract
Background— This study tested the hypothesis that sympathetic nerve activity is increased in pulmonary artery hypertension (PAH), a rare disease of poor prognosis and incompletely understood pathophysiology. We subsequently explored whether chemoreflex activation contributes to sympathoexcitation in PAH. Methods and Results— We measured muscle sympathetic nerve activity (MSNA) by microneurography, heart rate (HR), and arterial oxygen saturation (Sa o 2 ) in 17 patients with PAH and 12 control subjects. The patients also underwent cardiac echography, right heart catheterization, and a 6-minute walk test with dyspnea scoring. Circulating catecholamines were determined in 8 of the patients. Chemoreflex deactivation by 100% O 2 was assessed in 14 patients with the use of a randomized, double-blind, placebo-controlled, crossover study design. Compared with the controls, the PAH patients had increased MSNA (67±4 versus 40±3 bursts per minute; P <0.0001) and HR (82±4 versus 68±3 bpm; P =0.02). MSNA in the PAH patients was correlated with HR ( r =0.64, P =0.006), Sa o 2 ( r =−0.53, P =0.03), the presence of pericardial effusion ( r =0.51, P =0.046), and NYHA class ( r =0.52, P =0.033). The PAH patients treated with prostacyclin derivatives had higher MSNA ( P =0.009), lower Sa o 2 ( P =0.01), faster HR ( P =0.003), and worse NYHA class ( P =0.04). Plasma catecholamines were normal. Peripheral chemoreflex deactivation with hyperoxia increased Sa o 2 (91.7±1% to 98.4±0.2%; P <0.0001) and decreased MSNA (67±5 to 60±4 bursts per minute; P =0.0015), thereby correcting approximately one fourth of the difference between PAH patients and controls. Conclusions— We report for the first time direct evidence of increased sympathetic nerve traffic in advanced PAH. Sympathetic hyperactivity in PAH is partially chemoreflex mediated and may be related to disease severity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Psychophysical bases of perceived exertion
BORG, G. A. V. (1982) · Medicine & Science in Sports & Exercise · doi:10.1249/00005768-198205000-00012 · Cited by 16,580
Sahn, D. J., DeMaria, A., Kisslo, J., & Weyman, A. (1978) · Circulation · doi:10.1161/01.cir.58.6.1072 · Cited by 7,430
The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure.
Guyatt, G. H., Sullivan, M. J., Thompson, P. J., Fallen, E. L., Pugsley, S. O., Taylor, D. W., & Berman, L. (1985) · Europe PMC (PubMed Central) · Cited by 2,069
Primary Pulmonary Hypertension
Rubin, L. J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199701093360207 · Cited by 1,726
Sympathetic-Nerve Activity during Sleep in Normal Subjects
Somers, V. K., Dyken, M. E., Mark, A. L., & Abboud, F. M. (1993) · New England Journal of Medicine · doi:10.1056/nejm199302043280502 · Cited by 1,574
Appetite-suppressant drugs and the risk of primary pulmonary hypertension
Abenhaim, L., Moride, Y., Brenot, F., Rich, S., Benichou, J., Kurz, X., Higenbottam, T., Oakley, C., Wouters, E., Aubier, M., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608293350901 · Cited by 1,162
Nagaya, N., Nishikimi, T., Uematsu, M., Satoh, T., Kyotani, S., Sakamaki, F., Kakishita, M., Fukushima, K., Okano, Y., Nakanishi, N., et al. (2000) · Circulation · doi:10.1161/01.cir.102.8.865 · Cited by 876
Leimbach, W. N., Wallin, B. G., Victor, R. G., Aylward, P. E., Sundlöf, G., & Mark, A. L. (1986) · Circulation · doi:10.1161/01.cir.73.5.913 · Cited by 812
Preeclampsia — A State of Sympathetic Overactivity
Schobel, H. P., Fischer, T., Heuszer, K., Geiger, H., & Schmieder, R. E. (1996) · New England Journal of Medicine · doi:10.1056/nejm199611143352002 · Cited by 555
Narkiewicz, K., van de Borne, P. J. H., Montano, N., Dyken, M. E., Phillips, B. G., & Somers, V. K. (1998) · Circulation · doi:10.1161/01.cir.97.10.943 · Cited by 426
Self-citation
Cited by
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Humbert, M., Kovacs, G., Hoeper, M. M., Badagliacca, R., Berger, R. M. F., Brida, M., Carlsen, J., Coats, A. J. S., Escribano-Subias, P., Ferrari, P., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac237 · Cited by 3,975
Self-citation2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Humbert, M., Kovacs, G., Hoeper, M. M., Badagliacca, R., Berger, R. M. F., Brida, M., Carlsen, J., Coats, A. J. S., Escribano-Subias, P., Ferrari, P., et al. (2023) · European Respiratory Journal · doi:10.1183/13993003.00879-2022 · Cited by 2,247
Self-citationDysregulated Renin–Angiotensin–Aldosterone System Contributes to Pulmonary Arterial Hypertension
de Man, F. S., Tu, L., Handoko, M. L., Rain, S., Ruiter, G., François, C., Schalij, I., Dorfmüller, P., Simonneau, G., Fadel, E., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201203-0411oc · Cited by 346
Advances in Therapeutic Interventions for Patients With Pulmonary Arterial Hypertension
Humbert, M., Lau, E. M. T., Montani, D., Jaïs, X., Sitbon, O., & Simonneau, G. (2014) · Circulation · doi:10.1161/circulationaha.114.006974 · Cited by 342
Provencher, S., Herve, P., Jais, X., Lebrec, D., Humbert, M., Simonneau, G., & Sitbon, O. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.10.013 · Cited by 312
Metadata
- Authors
- Velez-Roa, S., Ciarka, A., Najem, B., Vachiery, J.-L., Naeije, R., & van de Borne, P.
- Venue
- Circulation
- Published
- 2004-09-07
- Volume
- 110
- Issue
- 10
- Pages
- 1308-1312
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2109070559
- Cited by
- 443
- References
- 31
- FWCI
- 4.42
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Increased Sympathetic Nerve Activity in Pulmonary Artery Hypertension. https://app.cochat.ai/papers/10.1161/01.cir.0000140724.90898.d3
- The paper
- Velez-Roa, S., Ciarka, A., Najem, B., Vachiery, J.-L., Naeije, R., & van de Borne, P. (2004). Increased Sympathetic Nerve Activity in Pulmonary Artery Hypertension. Circulation. https://doi.org/10.1161/01.cir.0000140724.90898.d3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.